Realistically, Clinton Is Not Anti-Healthcare-Stocks

These bearish sentiments first started with Valeant Pharmaceuticals, then Gilead and Turing Pharmaceuticals, and are now adversely affecting ETFs that hold any of these or their peers/competitors. It is my contention that the market is accustomed to common arbitrage opportunities, and when an even-driven opportunity emerges masking itself as a headwind, investors flee.